Herpes zoster: New insights provide an important wake-up call for management of nosocomial transmission

Journal of Infectious Diseases

Volumn 197, Issue 5, 2008, Pages 635-637

  Breuer, Judith ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VARICELLA ZOSTER VACCINE;

AGING; CLINICAL FEATURE; DISEASE TRANSMISSION; DRUG EFFECT; EDITORIAL; HERPES ZOSTER; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; POPULATION RESEARCH; PRIORITY JOURNAL; VIRUS VIRULENCE;

AEROSOLS; ANTIVIRAL AGENTS; CHICKENPOX; CHICKENPOX VACCINE; CROSS INFECTION; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; DNA, VIRAL; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; SALIVA;

EID: 40549131579     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/527421     Document Type: Editorial

References (23)

1. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44(Suppl 1):S1-26.
2. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84.
3. Lopez AS, Burnett-Hartman A, Nambiar R, et al. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 2008; 197:646-53 (in this issue).
4. Asano Y, Iwayama S, Miyata T, et al. Spread of varicella in hospitalized children having no direct contact with an indicator zoster case and its prevention by a live vaccine. Biken J 1980; 23:157-61.
5. Sawyer MH, Chamberlin CJ, Wu YN, Aintablian N, Wallace MR. Detection of varicellazoster virus DNA in air samples from hospital rooms. J Infect Dis 1994; 169:91-4.
6. Yoshikawa T, Ihira M, Suzuki K, et al. Rapid contamination of the environments with varicella-zoster virus DNA from a patient with herpes zoster. J Med Virol 2001; 63:64-6.
7. Ohashi M, Yoshikawa T, Ihira M, et al. Reactivation of human herpesvirus 6 and 7 in pregnant women. J Med Virol 2002; 67:354-8.
8. Suzuki K, Yoshikawa T, Ihira M, Ohashi M, Suga S, Asano Y. Spread of varicella-zoster virus DNA to the environment from varicella patients who were treated with oral acyclovir. Pediatr Int 2003; 45:458-60.
9. Suzuki K, Yoshikawa T, Tomitaka A, Matsunaga K, Asano Y. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. J Infect Dis 2004; 189:1009-12.
10. Wreghitt TG, Whipp J, Redpath C, Hollingworth W. An analysis of infection control of varicella-zoster virus infections in Addenbrooke's Hospital Cambridge over a 5-year period, 1987-92. Epidemiol Infect 1996; 117:165-71.
11. Quinlivan ML, Gershon AA, Al Bassam MM, et al. Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts. Proc Natl Acad Sci USA 2007; 104:208-12.
12. Loparev VN, Rubtcova E, Seward JF, Levin MJ, Schmid DS. DNA sequence variability in isolates recovered from patients with post-vaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis 2007; 195:502-10.
13. Norberg P, Liljeqvist JA, Bergström T, Sammons S, Schmid DS, Loparev VN. Complete-genome phylogenetic approach to varicellazoster virus evolution: genetic divergence and evidence for recombination. J Virol 2006; 80:9569-76.
14. Peters GA, Tyler SD, Grose C, et al. A full-genome phylogenetic analysis of varicellazoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J Virol 2006; 80:9850-60.
15. Schoub BD, Blackburn NK, Johnson S, McAnerney JM, Miller B. Low antibody avidity in elderly chickenpox patients. J Med Virol 1992; 37:113-5.
16. Hall S, Maupin T, Seward J, et al. Second varicella infections: are they more common than previously thought? Pediatrics 2002; 109:1068-73.
17. Mehta SK, Tyring SK, Gilden DH, et al. Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis 2008; 197:654-7 (in this issue).
18. Furuta Y, Fukuda S, Suzuki S, Takasu T, Inuyama Y, Nagashima K. Detection of varicella-zoster virus DNA in patients with acute peripheral facial palsy by the polymerase chain reaction, and its use for early diagnosis of zoster sine herpete. J Med Virol 1997; 52:316-9.
19. Furuta Y, Takasu T, Suzuki S, Fukuda S, Inuyama Y, Nagashima K. Detection of latent varicella-zoster virus infection in human vestibular and spiral ganglia. J Med Virol 1997; 51:214-6.
20. de Jong MD, Weel JF, Schuurman T, Wertheim-van Dillen PM, Boom R. Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence. J Clin Microbiol 2000; 38:2568-73.
21. Parker SP, Quinlivan M, Taha Y, Breuer J. Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR. J Clin Microbiol 2006; 44:3911-4.
22. Nagasako EM, Johnson RW, Griffin DR, Dworkin RH. Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol 2002; 46:834-9.
23. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/isolation2007.pdf.